Three-dose Pfizer Covid vaccine works safely in young children, review finds

Three doses of the Covid-19 vaccine from Pfizer Inc and BioNTech SE were effective in preventing symptomatic illness in children aged 6 months to 4 years in studies, according to US health officials.

FDA staff also said, in a review of the study data posted online Sunday, that there were no new safety concerns when using the vaccine in young children compared to older age groups.


Not all news on the site expresses the point of view of the site, but we transmit this news automatically and translate it through programmatic technology on the site and not from a human editor.
Back to top button